Global Wet Age Related Macular Degeneration (AMD) Supply, Demand and Key Producers, 2023-2029

Page: 107

Published Date: 06 Feb 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

Increased disease burden due to rising geriatric population is one of the major factors driving the growth of the global age-related macular degeneration (AMD) market. This market is expected to surpass a valuation of USD 2,200 Mn by the end of 2023. AMD remains a major cause of central visual loss, effecting close to 10% of people older than 65 years and over 25% of people older than 75 years globally.

This report studies the global Wet Age Related Macular Degeneration (AMD) demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Wet Age Related Macular Degeneration (AMD), and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Wet Age Related Macular Degeneration (AMD) that contribute to its increasing demand across many markets.

The global Wet Age Related Macular Degeneration (AMD) market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Increased awareness among people about the condition has influenced the AMD treatment global demand. At the same time, the arrival of off-patent blockbuster drugs is reflecting favorably on the market particularly in third-world countries. This has allowed small-scale drug manufactures to penetrate untapped markets.

Highlights and key features of the study
Global Wet Age Related Macular Degeneration (AMD) total market, 2018-2029, (USD Million)
Global Wet Age Related Macular Degeneration (AMD) total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Wet Age Related Macular Degeneration (AMD) total market, key domestic companies and share, (USD Million)
Global Wet Age Related Macular Degeneration (AMD) revenue by player and market share 2018-2023, (USD Million)
Global Wet Age Related Macular Degeneration (AMD) total market by Type, CAGR, 2018-2029, (USD Million)
Global Wet Age Related Macular Degeneration (AMD) total market by Age, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Wet Age Related Macular Degeneration (AMD) market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis International (Switzerland), Bayer (Germany), Acucela (US), Neurotech Pharmaceuticals (US), Ophthotech (US), GlaxoSmithKline (US), Alimera Sciences (US), StemCell (Canada) and F. Hoffmann-La Roche (Switzerland), etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Wet Age Related Macular Degeneration (AMD) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Age. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Wet Age Related Macular Degeneration (AMD) Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Wet Age Related Macular Degeneration (AMD) Market, Segmentation by Type
    Wet Age-Related Macular Degeneration (Wet AMD)
    Dry Age-Related Macular Degeneration (Dry AMD)

Global Wet Age Related Macular Degeneration (AMD) Market, Segmentation by Age
    Above 75 Years
    Above 60 Years
    Above 40 Years

Companies Profiled:
    Novartis International (Switzerland)
    Bayer (Germany)
    Acucela (US)
    Neurotech Pharmaceuticals (US)
    Ophthotech (US)
    GlaxoSmithKline (US)
    Alimera Sciences (US)
    StemCell (Canada)
    F. Hoffmann-La Roche (Switzerland)
    Regeneron Pharmaceutical (US)
    Allergan (Ireland)
    Adverum Biotechnologies (US)
    Gilead Sciences (US)

Key Questions Answered
1. How big is the global Wet Age Related Macular Degeneration (AMD) market?
2. What is the demand of the global Wet Age Related Macular Degeneration (AMD) market?
3. What is the year over year growth of the global Wet Age Related Macular Degeneration (AMD) market?
4. What is the total value of the global Wet Age Related Macular Degeneration (AMD) market?
5. Who are the major players in the global Wet Age Related Macular Degeneration (AMD) market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Wet Age Related Macular Degeneration (AMD) Introduction
    1.2 World Wet Age Related Macular Degeneration (AMD) Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Wet Age Related Macular Degeneration (AMD) Total Market by Region (by Headquarter Location)
        1.3.1 World Wet Age Related Macular Degeneration (AMD) Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Wet Age Related Macular Degeneration (AMD) Market Size (2018-2029)
        1.3.3 China Wet Age Related Macular Degeneration (AMD) Market Size (2018-2029)
        1.3.4 Europe Wet Age Related Macular Degeneration (AMD) Market Size (2018-2029)
        1.3.5 Japan Wet Age Related Macular Degeneration (AMD) Market Size (2018-2029)
        1.3.6 South Korea Wet Age Related Macular Degeneration (AMD) Market Size (2018-2029)
        1.3.7 ASEAN Wet Age Related Macular Degeneration (AMD) Market Size (2018-2029)
        1.3.8 India Wet Age Related Macular Degeneration (AMD) Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Wet Age Related Macular Degeneration (AMD) Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Wet Age Related Macular Degeneration (AMD) Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Wet Age Related Macular Degeneration (AMD) Consumption Value (2018-2029)
    2.2 World Wet Age Related Macular Degeneration (AMD) Consumption Value by Region
        2.2.1 World Wet Age Related Macular Degeneration (AMD) Consumption Value by Region (2018-2023)
        2.2.2 World Wet Age Related Macular Degeneration (AMD) Consumption Value Forecast by Region (2024-2029)
    2.3 United States Wet Age Related Macular Degeneration (AMD) Consumption Value (2018-2029)
    2.4 China Wet Age Related Macular Degeneration (AMD) Consumption Value (2018-2029)
    2.5 Europe Wet Age Related Macular Degeneration (AMD) Consumption Value (2018-2029)
    2.6 Japan Wet Age Related Macular Degeneration (AMD) Consumption Value (2018-2029)
    2.7 South Korea Wet Age Related Macular Degeneration (AMD) Consumption Value (2018-2029)
    2.8 ASEAN Wet Age Related Macular Degeneration (AMD) Consumption Value (2018-2029)
    2.9 India Wet Age Related Macular Degeneration (AMD) Consumption Value (2018-2029)

3 World Wet Age Related Macular Degeneration (AMD) Companies Competitive Analysis
    3.1 World Wet Age Related Macular Degeneration (AMD) Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Wet Age Related Macular Degeneration (AMD) Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Wet Age Related Macular Degeneration (AMD) in 2022
        3.2.3 Global Concentration Ratios (CR8) for Wet Age Related Macular Degeneration (AMD) in 2022
    3.3 Wet Age Related Macular Degeneration (AMD) Company Evaluation Quadrant
    3.4 Wet Age Related Macular Degeneration (AMD) Market: Overall Company Footprint Analysis
        3.4.1 Wet Age Related Macular Degeneration (AMD) Market: Region Footprint
        3.4.2 Wet Age Related Macular Degeneration (AMD) Market: Company Product Type Footprint
        3.4.3 Wet Age Related Macular Degeneration (AMD) Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Wet Age Related Macular Degeneration (AMD) Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Wet Age Related Macular Degeneration (AMD) Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Wet Age Related Macular Degeneration (AMD) Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Wet Age Related Macular Degeneration (AMD) Consumption Value Comparison
        4.2.1 United States VS China: Wet Age Related Macular Degeneration (AMD) Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Wet Age Related Macular Degeneration (AMD) Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Wet Age Related Macular Degeneration (AMD) Companies and Market Share, 2018-2023
        4.3.1 United States Based Wet Age Related Macular Degeneration (AMD) Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Wet Age Related Macular Degeneration (AMD) Revenue, (2018-2023)
    4.4 China Based Companies Wet Age Related Macular Degeneration (AMD) Revenue and Market Share, 2018-2023
        4.4.1 China Based Wet Age Related Macular Degeneration (AMD) Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Wet Age Related Macular Degeneration (AMD) Revenue, (2018-2023)
    4.5 Rest of World Based Wet Age Related Macular Degeneration (AMD) Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Wet Age Related Macular Degeneration (AMD) Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Wet Age Related Macular Degeneration (AMD) Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Wet Age Related Macular Degeneration (AMD) Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Wet Age-Related Macular Degeneration (Wet AMD)
        5.2.2 Dry Age-Related Macular Degeneration (Dry AMD)
    5.3 Market Segment by Type
        5.3.1 World Wet Age Related Macular Degeneration (AMD) Market Size by Type (2018-2023)
        5.3.2 World Wet Age Related Macular Degeneration (AMD) Market Size by Type (2024-2029)
        5.3.3 World Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2018-2029)

6 Market Analysis by Age
    6.1 World Wet Age Related Macular Degeneration (AMD) Market Size Overview by Age: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Age
        6.2.1 Above 75 Years
        6.2.2 Above 60 Years
        6.2.3 Above 40 Years
    6.3 Market Segment by Age
        6.3.1 World Wet Age Related Macular Degeneration (AMD) Market Size by Age (2018-2023)
        6.3.2 World Wet Age Related Macular Degeneration (AMD) Market Size by Age (2024-2029)
        6.3.3 World Wet Age Related Macular Degeneration (AMD) Market Size by Age (2018-2029)

7 Company Profiles
    7.1 Novartis International (Switzerland)
        7.1.1 Novartis International (Switzerland) Details
        7.1.2 Novartis International (Switzerland) Major Business
        7.1.3 Novartis International (Switzerland) Wet Age Related Macular Degeneration (AMD) Product and Services
        7.1.4 Novartis International (Switzerland) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Novartis International (Switzerland) Recent Developments/Updates
        7.1.6 Novartis International (Switzerland) Competitive Strengths & Weaknesses
    7.2 Bayer (Germany)
        7.2.1 Bayer (Germany) Details
        7.2.2 Bayer (Germany) Major Business
        7.2.3 Bayer (Germany) Wet Age Related Macular Degeneration (AMD) Product and Services
        7.2.4 Bayer (Germany) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Bayer (Germany) Recent Developments/Updates
        7.2.6 Bayer (Germany) Competitive Strengths & Weaknesses
    7.3 Acucela (US)
        7.3.1 Acucela (US) Details
        7.3.2 Acucela (US) Major Business
        7.3.3 Acucela (US) Wet Age Related Macular Degeneration (AMD) Product and Services
        7.3.4 Acucela (US) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Acucela (US) Recent Developments/Updates
        7.3.6 Acucela (US) Competitive Strengths & Weaknesses
    7.4 Neurotech Pharmaceuticals (US)
        7.4.1 Neurotech Pharmaceuticals (US) Details
        7.4.2 Neurotech Pharmaceuticals (US) Major Business
        7.4.3 Neurotech Pharmaceuticals (US) Wet Age Related Macular Degeneration (AMD) Product and Services
        7.4.4 Neurotech Pharmaceuticals (US) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Neurotech Pharmaceuticals (US) Recent Developments/Updates
        7.4.6 Neurotech Pharmaceuticals (US) Competitive Strengths & Weaknesses
    7.5 Ophthotech (US)
        7.5.1 Ophthotech (US) Details
        7.5.2 Ophthotech (US) Major Business
        7.5.3 Ophthotech (US) Wet Age Related Macular Degeneration (AMD) Product and Services
        7.5.4 Ophthotech (US) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Ophthotech (US) Recent Developments/Updates
        7.5.6 Ophthotech (US) Competitive Strengths & Weaknesses
    7.6 GlaxoSmithKline (US)
        7.6.1 GlaxoSmithKline (US) Details
        7.6.2 GlaxoSmithKline (US) Major Business
        7.6.3 GlaxoSmithKline (US) Wet Age Related Macular Degeneration (AMD) Product and Services
        7.6.4 GlaxoSmithKline (US) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 GlaxoSmithKline (US) Recent Developments/Updates
        7.6.6 GlaxoSmithKline (US) Competitive Strengths & Weaknesses
    7.7 Alimera Sciences (US)
        7.7.1 Alimera Sciences (US) Details
        7.7.2 Alimera Sciences (US) Major Business
        7.7.3 Alimera Sciences (US) Wet Age Related Macular Degeneration (AMD) Product and Services
        7.7.4 Alimera Sciences (US) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Alimera Sciences (US) Recent Developments/Updates
        7.7.6 Alimera Sciences (US) Competitive Strengths & Weaknesses
    7.8 StemCell (Canada)
        7.8.1 StemCell (Canada) Details
        7.8.2 StemCell (Canada) Major Business
        7.8.3 StemCell (Canada) Wet Age Related Macular Degeneration (AMD) Product and Services
        7.8.4 StemCell (Canada) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 StemCell (Canada) Recent Developments/Updates
        7.8.6 StemCell (Canada) Competitive Strengths & Weaknesses
    7.9 F. Hoffmann-La Roche (Switzerland)
        7.9.1 F. Hoffmann-La Roche (Switzerland) Details
        7.9.2 F. Hoffmann-La Roche (Switzerland) Major Business
        7.9.3 F. Hoffmann-La Roche (Switzerland) Wet Age Related Macular Degeneration (AMD) Product and Services
        7.9.4 F. Hoffmann-La Roche (Switzerland) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 F. Hoffmann-La Roche (Switzerland) Recent Developments/Updates
        7.9.6 F. Hoffmann-La Roche (Switzerland) Competitive Strengths & Weaknesses
    7.10 Regeneron Pharmaceutical (US)
        7.10.1 Regeneron Pharmaceutical (US) Details
        7.10.2 Regeneron Pharmaceutical (US) Major Business
        7.10.3 Regeneron Pharmaceutical (US) Wet Age Related Macular Degeneration (AMD) Product and Services
        7.10.4 Regeneron Pharmaceutical (US) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Regeneron Pharmaceutical (US) Recent Developments/Updates
        7.10.6 Regeneron Pharmaceutical (US) Competitive Strengths & Weaknesses
    7.11 Allergan (Ireland)
        7.11.1 Allergan (Ireland) Details
        7.11.2 Allergan (Ireland) Major Business
        7.11.3 Allergan (Ireland) Wet Age Related Macular Degeneration (AMD) Product and Services
        7.11.4 Allergan (Ireland) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Allergan (Ireland) Recent Developments/Updates
        7.11.6 Allergan (Ireland) Competitive Strengths & Weaknesses
    7.12 Adverum Biotechnologies (US)
        7.12.1 Adverum Biotechnologies (US) Details
        7.12.2 Adverum Biotechnologies (US) Major Business
        7.12.3 Adverum Biotechnologies (US) Wet Age Related Macular Degeneration (AMD) Product and Services
        7.12.4 Adverum Biotechnologies (US) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 Adverum Biotechnologies (US) Recent Developments/Updates
        7.12.6 Adverum Biotechnologies (US) Competitive Strengths & Weaknesses
    7.13 Gilead Sciences (US)
        7.13.1 Gilead Sciences (US) Details
        7.13.2 Gilead Sciences (US) Major Business
        7.13.3 Gilead Sciences (US) Wet Age Related Macular Degeneration (AMD) Product and Services
        7.13.4 Gilead Sciences (US) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 Gilead Sciences (US) Recent Developments/Updates
        7.13.6 Gilead Sciences (US) Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Wet Age Related Macular Degeneration (AMD) Industry Chain
    8.2 Wet Age Related Macular Degeneration (AMD) Upstream Analysis
    8.3 Wet Age Related Macular Degeneration (AMD) Midstream Analysis
    8.4 Wet Age Related Macular Degeneration (AMD) Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Wet Age Related Macular Degeneration (AMD) Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Wet Age Related Macular Degeneration (AMD) Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Wet Age Related Macular Degeneration (AMD) Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Wet Age Related Macular Degeneration (AMD) Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Wet Age Related Macular Degeneration (AMD) Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Wet Age Related Macular Degeneration (AMD) Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Wet Age Related Macular Degeneration (AMD) Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Wet Age Related Macular Degeneration (AMD) Players in 2022
    Table 12. World Wet Age Related Macular Degeneration (AMD) Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Wet Age Related Macular Degeneration (AMD) Company Evaluation Quadrant
    Table 14. Head Office of Key Wet Age Related Macular Degeneration (AMD) Player
    Table 15. Wet Age Related Macular Degeneration (AMD) Market: Company Product Type Footprint
    Table 16. Wet Age Related Macular Degeneration (AMD) Market: Company Product Application Footprint
    Table 17. Wet Age Related Macular Degeneration (AMD) Mergers & Acquisitions Activity
    Table 18. United States VS China Wet Age Related Macular Degeneration (AMD) Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Wet Age Related Macular Degeneration (AMD) Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Wet Age Related Macular Degeneration (AMD) Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Wet Age Related Macular Degeneration (AMD) Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Wet Age Related Macular Degeneration (AMD) Revenue Market Share (2018-2023)
    Table 23. China Based Wet Age Related Macular Degeneration (AMD) Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Wet Age Related Macular Degeneration (AMD) Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Wet Age Related Macular Degeneration (AMD) Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Wet Age Related Macular Degeneration (AMD) Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Wet Age Related Macular Degeneration (AMD) Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Wet Age Related Macular Degeneration (AMD) Revenue Market Share (2018-2023)
    Table 29. World Wet Age Related Macular Degeneration (AMD) Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Wet Age Related Macular Degeneration (AMD) Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Wet Age Related Macular Degeneration (AMD) Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Wet Age Related Macular Degeneration (AMD) Market Size by Age, (USD Million), 2018 & 2022 & 2029
    Table 33. World Wet Age Related Macular Degeneration (AMD) Market Size by Age (2018-2023) & (USD Million)
    Table 34. World Wet Age Related Macular Degeneration (AMD) Market Size by Age (2024-2029) & (USD Million)
    Table 35. Novartis International (Switzerland) Basic Information, Area Served and Competitors
    Table 36. Novartis International (Switzerland) Major Business
    Table 37. Novartis International (Switzerland) Wet Age Related Macular Degeneration (AMD) Product and Services
    Table 38. Novartis International (Switzerland) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Novartis International (Switzerland) Recent Developments/Updates
    Table 40. Novartis International (Switzerland) Competitive Strengths & Weaknesses
    Table 41. Bayer (Germany) Basic Information, Area Served and Competitors
    Table 42. Bayer (Germany) Major Business
    Table 43. Bayer (Germany) Wet Age Related Macular Degeneration (AMD) Product and Services
    Table 44. Bayer (Germany) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Bayer (Germany) Recent Developments/Updates
    Table 46. Bayer (Germany) Competitive Strengths & Weaknesses
    Table 47. Acucela (US) Basic Information, Area Served and Competitors
    Table 48. Acucela (US) Major Business
    Table 49. Acucela (US) Wet Age Related Macular Degeneration (AMD) Product and Services
    Table 50. Acucela (US) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Acucela (US) Recent Developments/Updates
    Table 52. Acucela (US) Competitive Strengths & Weaknesses
    Table 53. Neurotech Pharmaceuticals (US) Basic Information, Area Served and Competitors
    Table 54. Neurotech Pharmaceuticals (US) Major Business
    Table 55. Neurotech Pharmaceuticals (US) Wet Age Related Macular Degeneration (AMD) Product and Services
    Table 56. Neurotech Pharmaceuticals (US) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Neurotech Pharmaceuticals (US) Recent Developments/Updates
    Table 58. Neurotech Pharmaceuticals (US) Competitive Strengths & Weaknesses
    Table 59. Ophthotech (US) Basic Information, Area Served and Competitors
    Table 60. Ophthotech (US) Major Business
    Table 61. Ophthotech (US) Wet Age Related Macular Degeneration (AMD) Product and Services
    Table 62. Ophthotech (US) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Ophthotech (US) Recent Developments/Updates
    Table 64. Ophthotech (US) Competitive Strengths & Weaknesses
    Table 65. GlaxoSmithKline (US) Basic Information, Area Served and Competitors
    Table 66. GlaxoSmithKline (US) Major Business
    Table 67. GlaxoSmithKline (US) Wet Age Related Macular Degeneration (AMD) Product and Services
    Table 68. GlaxoSmithKline (US) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. GlaxoSmithKline (US) Recent Developments/Updates
    Table 70. GlaxoSmithKline (US) Competitive Strengths & Weaknesses
    Table 71. Alimera Sciences (US) Basic Information, Area Served and Competitors
    Table 72. Alimera Sciences (US) Major Business
    Table 73. Alimera Sciences (US) Wet Age Related Macular Degeneration (AMD) Product and Services
    Table 74. Alimera Sciences (US) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Alimera Sciences (US) Recent Developments/Updates
    Table 76. Alimera Sciences (US) Competitive Strengths & Weaknesses
    Table 77. StemCell (Canada) Basic Information, Area Served and Competitors
    Table 78. StemCell (Canada) Major Business
    Table 79. StemCell (Canada) Wet Age Related Macular Degeneration (AMD) Product and Services
    Table 80. StemCell (Canada) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. StemCell (Canada) Recent Developments/Updates
    Table 82. StemCell (Canada) Competitive Strengths & Weaknesses
    Table 83. F. Hoffmann-La Roche (Switzerland) Basic Information, Area Served and Competitors
    Table 84. F. Hoffmann-La Roche (Switzerland) Major Business
    Table 85. F. Hoffmann-La Roche (Switzerland) Wet Age Related Macular Degeneration (AMD) Product and Services
    Table 86. F. Hoffmann-La Roche (Switzerland) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. F. Hoffmann-La Roche (Switzerland) Recent Developments/Updates
    Table 88. F. Hoffmann-La Roche (Switzerland) Competitive Strengths & Weaknesses
    Table 89. Regeneron Pharmaceutical (US) Basic Information, Area Served and Competitors
    Table 90. Regeneron Pharmaceutical (US) Major Business
    Table 91. Regeneron Pharmaceutical (US) Wet Age Related Macular Degeneration (AMD) Product and Services
    Table 92. Regeneron Pharmaceutical (US) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Regeneron Pharmaceutical (US) Recent Developments/Updates
    Table 94. Regeneron Pharmaceutical (US) Competitive Strengths & Weaknesses
    Table 95. Allergan (Ireland) Basic Information, Area Served and Competitors
    Table 96. Allergan (Ireland) Major Business
    Table 97. Allergan (Ireland) Wet Age Related Macular Degeneration (AMD) Product and Services
    Table 98. Allergan (Ireland) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Allergan (Ireland) Recent Developments/Updates
    Table 100. Allergan (Ireland) Competitive Strengths & Weaknesses
    Table 101. Adverum Biotechnologies (US) Basic Information, Area Served and Competitors
    Table 102. Adverum Biotechnologies (US) Major Business
    Table 103. Adverum Biotechnologies (US) Wet Age Related Macular Degeneration (AMD) Product and Services
    Table 104. Adverum Biotechnologies (US) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. Adverum Biotechnologies (US) Recent Developments/Updates
    Table 106. Gilead Sciences (US) Basic Information, Area Served and Competitors
    Table 107. Gilead Sciences (US) Major Business
    Table 108. Gilead Sciences (US) Wet Age Related Macular Degeneration (AMD) Product and Services
    Table 109. Gilead Sciences (US) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 110. Global Key Players of Wet Age Related Macular Degeneration (AMD) Upstream (Raw Materials)
    Table 111. Wet Age Related Macular Degeneration (AMD) Typical Customers
List of Figure
    Figure 1. Wet Age Related Macular Degeneration (AMD) Picture
    Figure 2. World Wet Age Related Macular Degeneration (AMD) Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Wet Age Related Macular Degeneration (AMD) Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Wet Age Related Macular Degeneration (AMD) Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Wet Age Related Macular Degeneration (AMD) Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Wet Age Related Macular Degeneration (AMD) Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Wet Age Related Macular Degeneration (AMD) Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Wet Age Related Macular Degeneration (AMD) Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Wet Age Related Macular Degeneration (AMD) Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Wet Age Related Macular Degeneration (AMD) Revenue (2018-2029) & (USD Million)
    Figure 13. Wet Age Related Macular Degeneration (AMD) Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Wet Age Related Macular Degeneration (AMD) Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Wet Age Related Macular Degeneration (AMD) Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Wet Age Related Macular Degeneration (AMD) Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Wet Age Related Macular Degeneration (AMD) Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Wet Age Related Macular Degeneration (AMD) Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Wet Age Related Macular Degeneration (AMD) Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Wet Age Related Macular Degeneration (AMD) Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Wet Age Related Macular Degeneration (AMD) Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Wet Age Related Macular Degeneration (AMD) Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Wet Age Related Macular Degeneration (AMD) by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Wet Age Related Macular Degeneration (AMD) Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Wet Age Related Macular Degeneration (AMD) Markets in 2022
    Figure 27. United States VS China: Wet Age Related Macular Degeneration (AMD) Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Wet Age Related Macular Degeneration (AMD) Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Wet Age Related Macular Degeneration (AMD) Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Type in 2022
    Figure 31. Wet Age-Related Macular Degeneration (Wet AMD)
    Figure 32. Dry Age-Related Macular Degeneration (Dry AMD)
    Figure 33. World Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2018-2029)
    Figure 34. World Wet Age Related Macular Degeneration (AMD) Market Size by Age, (USD Million), 2018 & 2022 & 2029
    Figure 35. World Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Age in 2022
    Figure 36. Above 75 Years
    Figure 37. Above 60 Years
    Figure 38. Above 40 Years
    Figure 39. Wet Age Related Macular Degeneration (AMD) Industrial Chain
    Figure 40. Methodology
    Figure 41. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Wet Age Related Macular Degeneration (AMD) Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Wet Age Related Macular Degeneration (AMD) Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 07 Jan 2023

date Medical Care

Increased disease burden due to rising geriatric population is one of the major factors driving the growth of the global age-related macular degeneration (AMD) market. This market is expected to surpass a valuation of USD 2,200 Mn by the end of 2023. AMD remains a major cause of central visual loss, effecting close to 10% of people older than 65 years and over 25% of people older than 75 years globally.

Global Wet Age Related Macular Degeneration (AMD) Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Wet Age Related Macular Degeneration (AMD) Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Wet Age Related Macular Degeneration (AMD) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>